Serveur d'exploration SRAS - Corpus (PubMed)

Index « Auteurs » - entrée « Erik De Clercq »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Erik D. Olson < Erik De Clercq < Erik Lattwein  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000702 (2020) Guangdi Li ; Erik De ClercqTherapeutic options for the 2019 novel coronavirus (2019-nCoV).
000882 (2019) Tong Zhao ; Qing Meng ; Dongwei Kang ; Jianbo Ji ; Erik De Clercq ; Christophe Pannecouque ; Xinyong Liu ; Peng ZhanDiscovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing.
000905 (2019) Kaijun Jin ; Yali Sang ; Sheng Han ; Erik De Clercq ; Christophe Pannecouque ; Ge Meng ; Fener ChenSynthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.
000942 (2019) Zhao Wang ; Zhao Yu ; Dongwei Kang ; Jian Zhang ; Ye Tian ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Peng Zhan ; Xinyong LiuDesign, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
000A14 (2018) Xueyi Lu ; Jiapei Yang ; Dongwei Kang ; Ping Gao ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Peng Zhan ; Xinyong LiuThe discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2.
000A29 (2018) Zhongxia Zhou ; Tao Liu ; Dongwei Kang ; Zhipeng Huo ; Gaochan Wu ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Peng Zhan ; Xinyong LiuDiscovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".
000B05 (2017) Boshi Huang ; Xueshun Wang ; Xinhao Liu ; Zihui Chen ; Wanzhuo Li ; Songkai Sun ; Huiqing Liu ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Peng Zhan ; Xinyong LiuDiscovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays.
000C00 (2017) Xiao Li ; Ping Gao ; Boshi Huang ; Zhongxia Zhou ; Zhao Yu ; Zheng Yuan ; Huiqing Liu ; Christophe Pannecouque ; Dirk Daelemans ; Erik De Clercq ; Peng Zhan ; Xinyong LiuDiscovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement.
000C22 (2016) Xueyi Lu ; Xiao Li ; Jiapei Yang ; Boshi Huang ; Dongwei Kang ; Fabao Zhao ; Zhongxia Zhou ; Erik De Clercq ; Dirk Daelemans ; Christophe Pannecouque ; Peng Zhan ; Xinyong LiuArylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach.
000C80 (2016) Qing Meng ; Xuwang Chen ; Dongwei Kang ; Boshi Huang ; Wenxin Li ; Peng Zhan ; Dirk Daelemans ; Erik De Clercq ; Christophe Pannecouque ; Xinyong LiuDesign, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
000D14 (2016) Jiapei Yang ; Wenmin Chen ; Dongwei Kang ; Xueyi Lu ; Xiao Li ; Zhaoqiang Liu ; Boshi Huang ; Dirk Daelemans ; Christophe Pannecouque ; Erik De Clercq ; Peng Zhan ; Xinyong LiuDesign, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
000D84 (2015) Wenxin Li ; Xiao Li ; Erik De Clercq ; Peng Zhan ; Xinyong LiuDiscovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motif.
000E69 (2015) Boshi Huang ; Cuicui Li ; Wenmin Chen ; Tao Liu ; Mingyan Yu ; Lu Fu ; Yueyue Sun ; Huiqing Liu ; Erik De Clercq ; Christophe Pannecouque ; Jan Balzarini ; Peng Zhan ; Xinyong LiuFused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
000F10 (2015) Tao Liu ; Boshi Huang ; Ye Tian ; Xin Liang ; Hong Liu ; Huiqing Liu ; Peng Zhan ; Erik De Clercq ; Christophe Pannecouque ; Xinyong LiuDesign, Synthesis, and Biological Evaluation of Novel 4-Aminopiperidinyl-linked 3,5-Disubstituted-1,2,6-thiadiazine-1,1-dione Derivatives as HIV-1 NNRTIs.
000F27 (2014) Zhaoqiang Liu ; Wenmin Chen ; Peng Zhan ; Erik De Clercq ; Christophe Pannecouque ; Xinyong LiuDesign, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
000F41 (2014) Xiao Li ; Xueyi Lu ; Wenmin Chen ; Huiqing Liu ; Peng Zhan ; Christophe Pannecouque ; Jan Balzarini ; Erik De Clercq ; Xinyong LiuArylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
000F54 (2014) Liu Wang ; Ye Tian ; Wenmin Chen ; Hong Liu ; Peng Zhan ; Dongyue Li ; Huiqing Liu ; Erik De Clercq ; Christophe Pannecouque ; Xinyong LiuFused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach.
001003 (2014) Xiao Li ; Wenmin Chen ; Ye Tian ; Huiqing Liu ; Peng Zhan ; Erik De Clercq ; Christophe Pannecouque ; Jan Balzarini ; Xinyong LiuDiscovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach.
001019 (2014) Diwakar Rai ; Wenmin Chen ; Peng Zhan ; Hong Liu ; Ye Tian ; Xin Liang ; Erik De Clercq ; Christophe Pannecouque ; Jan Balzarini ; Xinyong LiuSynthesis and anti-HIV activity of 4-(naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl derivatives.
001033 (2014) Jun Wang ; Peng Zhan ; Zhenyu Li ; Huiqing Liu ; Erik De Clercq ; Christophe Pannecouque ; Xinyong LiuDiscovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.
001253 (2013) Dongyue Li ; Peng Zhan ; Huiqing Liu ; Christophe Pannecouque ; Jan Balzarini ; Erik De Clercq ; Xinyong LiuSynthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i -k "Erik De Clercq" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i  \
                -Sk "Erik De Clercq" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Erik De Clercq
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021